BridgeMD
New treatment option for Mental Disorders
Official title Implementation of REFOCUS Training Program in Mental Health Services
ClinicalTrials.gov ID: NCT05824234
What this study is testing
- What it's testing
- Training of mental health service teams in the orientation of care towards recovery through a 3-day training course: REFOCUS. This training aims to orient care towards recovery.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 15 to 65
You may be able to join if
- Age from 15 to 65 years old.
- Diagnosis of schizophrenia, schizoaffective disorder, schizotypal disorder and schizophreniform disorder or bipolar disorder, borderline personality...
- Patients cared for by the team or unit benefiting from REFOCUS training
- French mother tongue.
- Patient affiliated or entitled to a social security scheme
You likely can't join if
- Age less than 15 years old
- Patients under guardianship
- Presence of an associated intellectual disability
- Neurological disorders of vascular, infectious or neurodegenerative origin.
- Taking somatic drugs with a cerebral or psychic impact (eg corticosteroids).
See the full eligibility criteria
- Age from 15 to 65 years old.
- Diagnosis of schizophrenia, schizoaffective disorder, schizotypal disorder and schizophreniform disorder or bipolar disorder, borderline personality disorder, disabling anxiety or depressive disorder (DSM-V criteria...
- Patients cared for by the team or unit benefiting from REFOCUS training
- French mother tongue.
- Patient affiliated or entitled to a social security scheme
- Patient having received information about the study and having confirmed their participation in the study by signing the consent form
- For minors (\< 18 years), information given to holders of parental authority and signature of consent.
- For patients under curatorship, form signed by the patient and information given to the curator
- Age less than 15 years old
- Patients under guardianship
- Presence of an associated intellectual disability
- Neurological disorders of vascular, infectious or neurodegenerative origin.
- Taking somatic drugs with a cerebral or psychic impact (eg corticosteroids).
The study team makes the final eligibility decision.
Where it's taking place
- Lyon, Rhône, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 15 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lyon, Rhône, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.